2024-516936-93-02
EU Clinical Trials Information System
- Trial ID
- T-ctis-2024-516936-93-02
- Registry
- EU Clinical Trials Information System
- CTIS number
- 2024-516936-93-02
- Sponsor, as registered
- Amsterdam UMC
- Phase
- Therapeutic exploratory (Phase II)
- Indication
- chemotherapy-induced peripheral neuropathy, chronic neuropathic pain
- Status
- Authorised
- Start date
- 28/10/2025
- Primary completion
- CTIS does not publish one.
- Member states concerned
- Netherlands
- Sites
- 1
Member states whose regulator has a decision on this trial.
euclinicaltrials.euctis registryverified 2026-10-19
Notes on the record
New to data/trials.csv (no row for this CT number on main as of 2026-10-19); found by CTIS public search productName=psilocybin. Fields read from the CTIS public API retrieve record on 2026-10-19 17:33 CEST (publishDate 2025-11-12T02:32); site_count is the sum of trialSites across authorizedPartsII; codes not decoded; no primary completion date published.
Cited in
No published issue cites this registry number.